Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
29.27
-0.35 (-1.18%)
Dec 3, 2024, 12:23 PM EST - Market open
Artivion Revenue
Artivion had revenue of $95.78M in the quarter ending September 30, 2024, with 9.02% growth. This brings the company's revenue in the last twelve months to $384.90M, up 13.29% year-over-year. In the year 2023, Artivion had annual revenue of $354.00M with 12.82% growth.
Revenue (ttm)
$384.90M
Revenue Growth
+13.29%
P/S Ratio
3.19
Revenue / Employee
$256,599
Employees
1,500
Market Cap
1.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 354.00M | 40.22M | 12.82% |
Dec 31, 2022 | 313.79M | 14.95M | 5.00% |
Dec 31, 2021 | 298.84M | 45.61M | 18.01% |
Dec 31, 2020 | 253.23M | -23.00M | -8.32% |
Dec 31, 2019 | 276.22M | 13.38M | 5.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pediatrix Medical Group | 2.01B |
Embecta | 1.12B |
Tilray Brands | 812.04M |
Phreesia | 389.96M |
Innoviva | 352.75M |
Aurinia Pharmaceuticals | 220.36M |
Establishment Labs Holdings | 153.07M |
BioLife Solutions | 146.96M |
AORT News
- 24 days ago - Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Artivion Reports Third Quarter 2024 Financial Results - PRNewsWire
- 27 days ago - Artivion to Participate in Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results - PRNewsWire
- 7 weeks ago - Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PRNewsWire
- 4 months ago - Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Artivion Reports Second Quarter 2024 Financial Results - PRNewsWire
- 4 months ago - Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results - PRNewsWire